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Abstract
Introduction: Systemic hypersensitivity reactions to topical ophthalmic treatment occur rarely,
but when they do they can be severe as highlighted by this case.
Case presentation: A post-operative cataract surgery patient developed a severe and
generalised hypersensitivity reaction following topical treatment with Maxitrol (Dexamethasone
and Neomycin) eye drops. The patient reported a previous allergic reaction to Neomycin.
Conclusion: This case report emphasises the importance of a thorough drug and allergy history
when patients are seen at pre-assessment or clerked in for surgery.
Introduction
Adverse external ocular effects of topical ophthalmic ther-
apy have been estimated to occur in 10 % of all adverse
reactions [1].
Drug-related ocular allergies are often the result of type IV
hypersensitivity reactions, although type 1 and type 3
hypersensitivity reactions may also be involved [2].
Hypersensitivity to localised ocular therapy may involve a
localised contact reaction which may include itching, red-
ness, tearing, mucopurulent discharge, and papillary con-
junctivitis as well as corneal involvement [3]. Dermatitis,
oedema and chemosis of the eyelids and skin can also
occur [4].
Anaphylactoid reactions are rare and can be the result of
type 1 (immediate) hypersensitivity reactions [1]. They
are not usually associated with systemic anaphylaxis but
involve an acute shock syndrome that may be immuno-
logically mediated [5].
Anaphylactoid reactions are characterised by acute itch-
ing, conjunctival hyperemia, chemosis and oedema of
skin in the form of urticaria and angioedema Neomycin is
an antibiotic that is often used in the form of Maxitrol
(Neomycin, Polymyxin B and Dexamethasone) after cata-
ract surgery in the prophylaxis of infection.
When used in ophthalmic preparations, it is well known
to be a cause of allergic localised contact reactions, but it
is rare for it to cause a diffuse cutaneous systemic reaction
[6]. One study has estimated the incidence of allergic con-
tact reactions to topical neomycin as 1 to 29/100,000 [7].
We describe a case of severe systemic allergy with a diffuse
cutaneous hypersensitivity reaction following topical
ophthalmic administration of neomycin in the form of
Maxitrol.
Case presentation
An 80 year old Caucasian male underwent routine
phacoemulsification cataract extraction with posterior
chamber intraocular lens implant.
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lesterolemia for which he was using Atenolol and Simvas-
tatin. He also had a history of bladder cancer for which he
had received chemotherapy and radiotherapy.
Of note, the patient had reported an allergic reaction to
Neomycin ear drops 30 years previously. This had left him
with a rash that improved a few days later.
The patient was discharged after a straight forward cataract
operation on Maxitrol eye drops four times a day.
He was seen the next day for the first post-operative visit,
and up until then had used Maxitrol twice to the affected
eye.
At that stage the patient's eye was noted to be slightly
more injected than usual but no further concerns were
raised. Papillae were noted on the palpebral conjunctiva
and treatment was continued.
The patient was then reviewed 2 weeks post-operatively
and had continued to use Maxitrol up until that time. He
was found to have increased facial erythema, swelling and
crusting around the lids. (see Fig. 1). He also complained
of a severe and generalised rash affecting his legs, arms,
back and buttocks which was painful. (Figs. 2 and 3). No
other mucus membranes were involved.
Generalised hypersensitivity reaction involving the trunk and lower limbsFigu e 2
Generalised hypersensitivity reaction involving the 
trunk and lower limbs.
Severe pruritic periorbital rash and swelling around left eyeFigu e 1
Severe pruritic periorbital rash and swelling around 
left eye.
Maculo-papular rash – Involvement of the lower limbFigure 3
Maculo-papular rash – Involvement of the lower 
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Treatment with systemic Prednisone 20 mg once a day
and Betnovate eye ointment relieved his symptoms
remarkably, and 3 weeks later all signs of inflammation
were gone.
Conclusion
Systemic hypersensitivity reactions to topical ophthalmic
treatment occur rarely. but when they do they can be
severe as highlighted by this case.
Although the patient in this report had a substantial
improvement in best-corrected visual acuity from count-
ing fingers pre-operatively to 6/9 post-operatively, he
endured a long and painful recovery which otherwise
would have been quick and straight forward. An alterna-
tive post-operative regime could have been Pred Forte and
Chloramphenicol eye drops four times a day.
This case report emphasises the importance of a thorough
drug and allergy history when patients are seen at pre-
assessment or clerked in for surgery. Even when drugs are
given topically and locally, the possibility of a severe sys-
temic reaction should always be borne in mind even
though these are rare. As physicians it is also important for
us to educate our patients about the signs and symptoms
of such an allergic reaction so the patient will return to us
sooner for treatment.
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